Ray Therapeutics

About:

Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.

Website: https://raytherapeutics.com

Top Investors: Norwest Venture Partners, MRL Ventures Fund, Deerfield, Novo Holdings, California Institute for Regenerative Medicine

Description:

Ray Therapeutics is a company that creates novel optogenetic gene therapies for patients with blinding diseases. The company develops technology to study and learn about rare retinal diseases, allowing doctors to cure and treat inherited retinal diseases using optogenetics.

Total Funding Amount:

$114M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2021-01-01

Founders:

Paul Bresge

Number of Employees:

1-10

Last Funding Date:

2023-11-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai